Research Summary

Analyzed using Evidence Intelligence™

Exercise therapy reduces blood pressure in multimorbidity.

Last updated July 18, 2026

Key finding

Compared to usual care, the intervention group shows a statistically significant reduction in systolic blood pressure (mean difference: -4.7 mmHg, 95% CI: -8.8 to -0.6).

A 12-week personalized exercise and self-management program significantly reduced systolic blood pressure in individuals with multimorbidity.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Long-Term (1–5 y)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

A 12-week personalized exercise and self-management program significantly reduced systolic blood pressure in individuals with multimorbidity.

Clinical relevance

Managing blood pressure is crucial for individuals with multimorbidity, as it can reduce the risk of cardiovascular events and improve overall health outcomes. This study highlights the potential of personalized exercise programs as a viable intervention to enhance health management in this population, suggesting that such programs could be integrated into routine care.

Keep in mind

The study may have limited generalizability due to the specific population studied. Potential unmeasured confounders could affect the outcomes. The sample size and duration may limit the robustness of the findings.

Published in

Journal Reference

Publication details and source links for this paper.

Alessio B, Mette N, Grit EL, et al. A 12-week personalised exercise and self-management programme reduces systolic blood pressure in people with multimorbidity. Communications Medicine. 2026;6:213. doi:10.1038/s43856-026-01479-9

View DOI View on PubMed View on PMC

Main Effects

The intervention group showed a significant reduction in systolic blood pressure by -4.7 mmHg compared to usual care.

No significant differences were observed for IL-1ra, hs-CRP, TNF-α, IL-6, HbA1c, fasting plasma glucose, fasting insulin, HDL, and LDL, although trends favored the intervention.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Exercise therapy and C-reactive protein, Change in IL-1ra levels, Fasting Plasma Glucose (FPG), and 8 more.

This study contributes evidence to

Intervention

Exercise therapy

Outcome

C-reactive protein

Evidence topic

Cardiometabolic Risk

Primary intervention

Exercise therapy

Primary outcomes

C-reactive protein
Change in IL-1ra levels
Fasting Plasma Glucose (FPG)

Evidence topics

Cardiometabolic Risk Insulin Resistance Prediabetes Inflammatory and Vascular Markers

Primary intervention

Exercise therapy

Primary outcomes

C-reactive protein Change in IL-1ra levels Fasting Plasma Glucose (FPG)

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

Evidence pairs

Relationships

Evidence topics

contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 72

Why it is useful

Contributes to 11 evidence relationships
Includes primary outcome data
Linked to 6 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence topic

Cardiometabolic Risk

matched_intervention_and_outcome

Related evidence

Evidence topic

Insulin Resistance

Save evidence

Core evidence

Study findings

The primary outcomes reported in this study.

C-reactive protein

Exercise therapy → C-reactive protein

Evidence Intelligence™

EvidenceScore™: Moderate; Score 69 · Based on 2 studies
ImpactScore™: 75; Positive
ConsistencyScore™: 35; mixed

Based on 2 studies

Add to Evidence Tracker

Change in IL-1ra levels

Exercise therapy → Change in IL-1ra levels

Evidence Intelligence™

EvidenceScore™: Emerging; Score 59 · Based on 1 study
ImpactScore™: 50; Neutral
ConsistencyScore™: unclear; Not enough independent studies

Based on 1 study

Add to Evidence Tracker

Fasting insulin levels

Exercise therapy → Fasting insulin levels

Evidence Intelligence™

EvidenceScore™: Emerging; Score 59 · Based on 1 study
ImpactScore™: 50; Neutral
ConsistencyScore™: unclear; Not enough independent studies

Based on 1 study

Add to Evidence Tracker

Fasting Plasma Glucose (FPG)

Exercise therapy → Fasting Plasma Glucose (FPG)

Evidence Intelligence™

EvidenceScore™: Emerging; Score 59 · Based on 1 study
ImpactScore™: 50; Neutral
ConsistencyScore™: unclear; Not enough independent studies

Based on 1 study

Add to Evidence Tracker

HbA1c

Exercise therapy → HbA1c

Evidence Intelligence™

EvidenceScore™: 81; Strong
ImpactScore™: 84; Positive
ConsistencyScore™: 83; consistent

Based on 6 studies

Add to Evidence Tracker

HDL cholesterol

Exercise therapy → HDL cholesterol

Evidence Intelligence™

EvidenceScore™: Emerging; Score 59 · Based on 1 study
ImpactScore™: 50; Neutral
ConsistencyScore™: unclear; Not enough independent studies

Based on 1 study

Add to Evidence Tracker

Interleukin-6 (IL-6)

Exercise therapy → Interleukin-6 (IL-6)

Evidence Intelligence™

EvidenceScore™: Strong; Score 79 · Based on 4 studies
ImpactScore™: 88; Very Positive
ConsistencyScore™: 75; consistent

Based on 4 studies

Add to Evidence Tracker

LDL cholesterol

Exercise therapy → LDL cholesterol

Evidence Intelligence™

EvidenceScore™: Emerging; Score 59 · Based on 1 study
ImpactScore™: 50; Neutral
ConsistencyScore™: unclear; Not enough independent studies

Based on 1 study

Add to Evidence Tracker

Systolic blood pressure

Exercise therapy → Systolic blood pressure

Evidence Intelligence™

EvidenceScore™: Strong; Score 79 · Based on 3 studies
ImpactScore™: 83; Positive
ConsistencyScore™: 100; consistent

Based on 3 studies

Add to Evidence Tracker

Triglycerides

Exercise therapy → Triglycerides

Evidence Intelligence™

EvidenceScore™: Emerging; Score 59 · Based on 1 study
ImpactScore™: 50; Neutral
ConsistencyScore™: unclear; Not enough independent studies

Based on 1 study

Add to Evidence Tracker

Tumor Necrosis Factor-alpha (TNF-α)

Exercise therapy → Tumor Necrosis Factor-alpha (TNF-α)

Evidence Intelligence™

EvidenceScore™: Strong; Score 79 · Based on 3 studies
ImpactScore™: 83; Positive
ConsistencyScore™: 67; generally_consistent

Based on 3 studies

Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Evidence Suggest

Systolic blood pressure decreased by 4.7 mmHg in the intervention group (p=0.001).
No significant changes were found in inflammatory markers, although results favored the intervention.

Who this applies to

Adults with multimorbidity, including chronic conditions such as hypertension and diabetes.
Individuals seeking non-pharmacological interventions to manage blood pressure.

Keep in Mind

The findings are based on a specific 12-week intervention and may not apply to longer-term outcomes.
The study's results should be interpreted with caution due to potential limitations in sample diversity.
Further research is needed to explore the effects on other health markers and long-term benefits.

Between the Lines

The study may have limited generalizability due to the specific population studied.
Potential unmeasured confounders could affect the outcomes.
The sample size and duration may limit the robustness of the findings.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Exercise therapy and HbA1c, Exercise therapy and Inflammatory Markers.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Physical Activity

Detailed evidence

Exercise therapy → HbA1c

Physical Activity

Evidence Intelligence™

EvidenceScore™: 81; Strong
ImpactScore™: 84; Positive
ConsistencyScore™: 83; consistent

Based on 6 studies

View evidence

Physical Activity

Detailed evidence

Exercise therapy → Inflammatory Markers

Physical Activity

Evidence Intelligence™

EvidenceScore™: Strong; Score 79 · Based on 4 studies
ImpactScore™: 88; Very Positive
ConsistencyScore™: 75; consistent

Based on 4 studies

View evidence

Physical Activity

Detailed evidence

Exercise therapy → Blood Pressure

Physical Activity

Evidence Intelligence™

EvidenceScore™: Strong; Score 79 · Based on 3 studies
ImpactScore™: 83; Positive
ConsistencyScore™: 100; consistent

Based on 3 studies

View evidence

Included in these evidence collections

Curated evidence collections and hubs this study is part of.

Exercise therapy Evidence Hub

All studies on Exercise therapy

6 studies

intervention_hub

Contributes to Exercise therapy evidence base.

HbA1c Evidence Hub

All studies measuring HbA1c

6 studies

outcome_hub

Measures HbA1c as a key outcome.

Inflammatory Markers Evidence Hub

All studies measuring Inflammatory Markers

4 studies

outcome_hub

Measures Inflammatory Markers as a key outcome.

Blood Pressure Evidence Hub

All studies measuring Blood Pressure

3 studies

outcome_hub

Measures Blood Pressure as a key outcome.

Recent Diabetes Research

Latest published studies

recency_collection

Published within the last 2 years.

Explore more in Evidence Explorer

Jump to pre-filtered views in Evidence Explorer.

All studies on Exercise therapy and HbA1c

Intervention: Exercise therapyOutcome: HbA1c

6 results

All studies on Exercise therapy and Interleukin-6 (IL-6)

Intervention: Exercise therapyOutcome: Interleukin-6 (IL-6)

4 results

All studies on Exercise therapy

Intervention: Exercise therapy

6 results

All studies measuring HbA1c

Outcome: HbA1c

6 results

All studies measuring Interleukin-6 (IL-6)

Outcome: Interleukin-6 (IL-6)

4 results

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Exercise therapy improve HbA1c?

Strong Evidence

Exercise therapy may improve HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 81.1 | moderate positive | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.
Population details are unavailable.

View Full Evidence

Does Exercise therapy improve interleukin-6 (il-6)?

Strong Evidence

Exercise therapy appears to improve Interleukin-6 (IL-6).

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Interleukin-6 (IL-6)
EvidenceScore™ Strong | EvidenceScore™ 79.0 | strong positive | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.
Population details are unavailable.

View Full Evidence

Does Exercise therapy improve systolic blood pressure?

Strong Evidence

Exercise therapy may improve Systolic blood pressure.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Systolic blood pressure
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.
Population details are unavailable.

View Full Evidence

Does Exercise therapy improve tumor necrosis factor-alpha (tnf-α)?

Strong Evidence

Exercise therapy may improve Tumor Necrosis Factor-alpha (TNF-α).

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

1
Tumor Necrosis Factor-alpha (TNF-α)
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

Only one supporting study is available.
Population details are unavailable.

View Full Evidence

Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Evidence topics

Follow the topics this study contributes to.

Cardiometabolic Risk Evidence Hub Insulin Resistance Evidence Hub Prediabetes Evidence Hub Inflammatory and Vascular Markers Evidence Hub

Explore in Evidence Explorer

Open broader Evidence Explorer views for this relationship.

All studies on Exercise therapy and Systolic blood pressure All studies on Exercise therapy and HbA1c All studies on Exercise therapy and Interleukin-6 (IL-6)All studies on Exercise therapy and Tumor Necrosis Factor-alpha (TNF-α)

Related research

Read related research summaries.

Combining Exercise and Polyphenols Improves Glycemic Control in Prediabetes HRS-7535 improves glycemic control in adults with type 2 diabetes Intermittent Fasting Diet Improves Glycemic Control in Type 2 Diabetes Mediterranean ketogenic eating matched VLCKD for weight loss over 3 months Taichi training improves lung function and blood sugar control in diabetes

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.